Pharmacokinetics of escitalopram in healthy volunteers
Jun Chen
Abstract
Jun Chen
Abstract
AIM:To study the pharmacokinetics of escitalopram in healthy Chinese volunteers.METHODS: The volunteers were given a single oral dose of 5,10 or 20 mg escitalopram for single dose pharmacokinetics, or 10 mg escitalopram tablets once a day for 10-days multidose and steady-state study.The plasma concentrations of escitalopram were determined by a validated HPLC-MS/MS method.The pharmacokinetic parameters were calculated by DAS 2.0 software.RESULTS:The main pharmacokinetic parameters of escitalopram after the single oral dose of 5,10 or 20 mg were as follows:AUC_(0-144) were (219±s 49),(367±60) and (689±174)μg·h·L~(-1),respectively;AUC_(0-∞) (242±64),(414±79) and (745±207)μg·h·L~(-1);c_(max) (5.5±1.0), (8.8±1.3) and (21±6)μg·L~(-1);t_(max) (4±3),(6±3) and (3.0±1.5) h;t_(1/2) (40±11),(48±10) and (37±6) h;MRT (56±13),(63±11) and (51±7) h.The parameters after multidose of 10 mg were as follows:AUC_(0-144) was (914±202)μg·h·L~(-1),AUC_(0-∞) (993±214)μg·h·L~(-1),AUC_(ss) (364±78)μg·h·L~(-1), c_(max)~(ss)(26±4)μg·L~(-1),c_(min)~(ss)(12.4±1.1)μg·L~(-1),c_(av)~(ss)(15±3)μg·L~(-1),DF 0.87±0.22,t_(max) (2.6±1.7) h,t_(1/2) (40±7) h.CONCLUSION:The plasma concentration-time curve of escitalopram is fitted with a two- compartment open pharmacokinetic model.The c_(max) and AUC are proportional with the dose ranged from 5 to 20 mg,respectively,while the t_(max),t_(1/2),and MRT are not affected by the dose.Therefore,the linear pharmacokinetics of escitalopram in human plasma is found in Chinese healthy volunteers.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM:To study the pharmacokinetics of escitalopram in healthy Chinese volunteers.METHODS: The volunteers were given a single oral dose of 5,10 or 20 mg escitalopram for single dose pharmacokinetics, or 10 mg escitalopram tablets once a day for 10-days multidose and steady-state study.The plasma concentrations of escitalopram were determined by a validated HPLC-MS/MS method.The pharmacokinetic parameters were calculated by DAS 2.0 software.RESULTS:The main pharmacokinetic parameters of escitalopram after the single oral dose of 5,10 or 20 mg were as follows:AUC_(0-144) were (219±s 49),(367±60) and (689±174)μg·h·L~(-1),respectively;AUC_(0-∞) (242±64),(414±79) and (745±207)μg·h·L~(-1);c_(max) (5.5±1.0), (8.8±1.3) and (21±6)μg·L~(-1);t_(max) (4±3),(6±3) and (3.0±1.5) h;t_(1/2) (40±11),(48±10) and (37±6) h;MRT (56±13),(63±11) and (51±7) h.The parameters after multidose of 10 mg were as follows:AUC_(0-144) was (914±202)μg·h·L~(-1),AUC_(0-∞) (993±214)μg·h·L~(-1),AUC_(ss) (364±78)μg·h·L~(-1), c_(max)~(ss)(26±4)μg·L~(-1),c_(min)~(ss)(12.4±1.1)μg·L~(-1),c_(av)~(ss)(15±3)μg·L~(-1),DF 0.87±0.22,t_(max) (2.6±1.7) h,t_(1/2) (40±7) h.CONCLUSION:The plasma concentration-time curve of escitalopram is fitted with a two- compartment open pharmacokinetic model.The c_(max) and AUC are proportional with the dose ranged from 5 to 20 mg,respectively,while the t_(max),t_(1/2),and MRT are not affected by the dose.Therefore,the linear pharmacokinetics of escitalopram in human plasma is found in Chinese healthy volunteers.
Key concepts: Pharmacokinetics, Escitalopram, Pharmacology, Plasma concentration, Chemistry, Medicine, Internal medicine, Hippocampus